Use of Patoladi Kushtahar Kashay in comparison with Tablet Fluconazole in Fungal Infection.

Assessment of effect of Patoladi Kushtahar Kashay in comparison with tablet Fluconazole in management of dadru-open randomized control study. - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063366

Enrollment

Registered

2024-02-29

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B49- Unspecified mycosis

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1-Patient of both genders 2-Patient in the age group of 18 – 60 yrs. of age. 3-Patient presenting Classical sign and symptoms like kandu,raga,pidika will be taken. 4-Patients having symptoms upto 3 months.

Exclusion criteria

Exclusion criteria: subjects having any acute systemic illness uncontrolled DM etc. 1-Immuno-compromised patients. 2-Pregnant and lactating mothers 3-K/C/O immuno compromising conditions or on immunosuppressive drugs

Design outcomes

Primary

Measure	Time frame
Assessment of the efficacy of Patoladi Kushtahar Kashay in management of Dadru.Timepoint: The study will be conducted for 4weeks. Follow up- 0th day,1st week,2nd week,3rd week,4th week.	—

Secondary

Measure	Time frame
Study the probable mode of action of Patoladi Kushtahar Kashay in management of Dadru.Timepoint: Study will be conducted for 4weeks. Follow up- 0th day,1st week,2nd week,3rd week,4th week.	—

Countries

India

Contacts

Public ContactDr Mohini Sunil Phadtare

Dr. G. D.Pol Foundation, YMT Ayurvedic Medical Collage.Kharghar. Navi Mumbai

drpandeymahesh@gmail.com9820006082

Outcome results